Clinical significance and prospects of using ST2 in ischemic heart failure patients
Journal: Сибирский журнал клинической и экспериментальной медицины @cardiotomsk
Section: Клинические исследования
Article in issue: 2 т.35, 2020.
Free access
Objective: The objective of this study is to assess the role of soluble ST2 (sST2) in developing adverse cardiovascular events (ACE) and fatal outcomes in patients with chronic heart failure (HF) during 18 [12.5; 35.5]-month follow-up period.Results. Depending on the median of baseline sST2 levels, all patients were retrospectively divided into two groups: group 1 enrolled patients with sST2 levels
Similar articles in the section Pathology of the circulatory system, blood vessels. Cardiovascular complaints
Short address: https://sciup.org/149126185
IDS: 149126185 | UDC: 616.12-008.46-036.12-02:616.12-005.4 | DOI: 10.29001/2073-8552-2020-35-2-89-97